Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells

2005 ◽  
Vol 94 (1-3) ◽  
pp. 189-196 ◽  
Author(s):  
Nadja Nazarova ◽  
Olga Golovko ◽  
Merja Bläuer ◽  
Pentti Tuohimaa
1994 ◽  
Vol 267 (6) ◽  
pp. C1674-C1681 ◽  
Author(s):  
S. Ali ◽  
G. W. Dorn

Vascular smooth muscle cells (VSMC) undergo hypertrophy when exposed to thromboxane A2 and hyperplasia when exposed to phorbol 12-myristate 13-acetate (PMA) or platelet-derived growth factor (PDGF). Each of these three agonists stimulate rapid tyrosine phosphorylation of numerous VSMC proteins. The current studies were undertaken to identify proteins that are specifically tyrosine phosphorylated in one or the other growth response. All three agonists increased the phosphotyrosine content of multiple proteins. In Western analysis of phosphotyrosine immunoprecipitates, the hyperplastic agents PDGF and PMA increased tyrosine phosphorylation of phospholipase C-gamma 1 (PLC-gamma 1), GTPase-activating protein (GAP), and phosphatidylinositol-3-kinase (PI-3-kinase), while the hypertrophic agonist thromboxane failed to tyrosine-phosphorylate either of these three substrates. Tyrosine kinase inhibition with herbimycin A (5 microM) prevented agonist-stimulated tyrosine phosphorylation of PLC-gamma 1, GAP, and PI-3-kinase. In growth studies, herbimycin A inhibited PMA- and PDGF-induced hyperplasia but not thromboxane-stimulated hypertrophy. These results indicate that tyrosine phosphorylation of PLC-gamma 1, GAP, and PI-3-kinase are specific responses for VSMC hyperplasia but not thromboxane-stimulated hypertrophy.


Pharmacology ◽  
2001 ◽  
Vol 62 (2) ◽  
pp. 103-106 ◽  
Author(s):  
Mark A. Pullen ◽  
Katherine Thomas ◽  
Hsiao-Ling Wu ◽  
Ponnal Nambi

1995 ◽  
Vol 143 (2) ◽  
pp. 229 ◽  
Author(s):  
Steven P. Howard ◽  
Kevin M. Groch ◽  
Mary J. Lindstrom ◽  
Edward M. Messing ◽  
Michael N. Gould

1995 ◽  
Vol 268 (4) ◽  
pp. C1033-C1039 ◽  
Author(s):  
C. Rechtoris ◽  
T. Mazzone

We investigated the effect of recombinant platelet-derived growth factor (PDGF) isomers on low-density lipoprotein (LDL) receptor gene expression and compared this with two indexes of cell growth response: expression of the immediate early gene c-myc and the rate of DNA synthesis. In human skin fibroblasts and NIH 3T3 cells, the PDGF-BB homodimer was more effective in inducing the LDL receptor gene and cell growth response compared with the PDGF-AA homodimer. The second messenger pathways utilized by PDGF receptors for enhancing LDL receptor gene response could, however, be dissociated from those utilized for enhancing c-myc gene response and were insensitive to inhibitors of tyrosine phosphorylation. Inhibition of tyrosine kinase activity inhibited c-myc gene response to PDGF-BB at 10(-8) M but had little effect on LDL receptor gene response. Such inhibition increased expression of the LDL receptor gene in the presence of the PDGF-AA isomer. Our results indicate that the response of the LDL receptor gene to PDGF isoforms reflects cellular growth response. However, different transduction pathways are utilized for PDGF activation of the c-myc and LDL receptor genes in mesenchymal cells.


Sign in / Sign up

Export Citation Format

Share Document